435 related articles for article (PubMed ID: 25566680)
1. Omalizumab for the treatment of chronic urticaria.
Zuberbier T; Maurer M
Expert Rev Clin Immunol; 2015 Feb; 11(2):171-80. PubMed ID: 25566680
[TBL] [Abstract][Full Text] [Related]
2. Chronic urticaria: omalizumab and review of therapeutic options.
Bergstrom KG
J Drugs Dermatol; 2013 Jun; 12(6):715-6. PubMed ID: 23839196
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
Maurer M; Rosén K; Hsieh HJ; Saini S; Grattan C; Gimenéz-Arnau A; Agarwal S; Doyle R; Canvin J; Kaplan A; Casale T
N Engl J Med; 2013 Mar; 368(10):924-35. PubMed ID: 23432142
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
Kaplan A; Ledford D; Ashby M; Canvin J; Zazzali JL; Conner E; Veith J; Kamath N; Staubach P; Jakob T; Stirling RG; Kuna P; Berger W; Maurer M; Rosén K
J Allergy Clin Immunol; 2013 Jul; 132(1):101-9. PubMed ID: 23810097
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic autoimmune urticaria with omalizumab.
Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
Maurer M; Altrichter S; Bieber T; Biedermann T; Bräutigam M; Seyfried S; Brehler R; Grabbe J; Hunzelmann N; Jakob T; Jung A; Kleine-Tebbe J; Mempel M; Meurer M; Reich K; Ruëff F; Schäkel K; Sengupta K; Sieder C; Simon JC; Wedi B; Zuberbier T; Mahler V; Staubach P
J Allergy Clin Immunol; 2011 Jul; 128(1):202-209.e5. PubMed ID: 21636116
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab in chronic urticaria.
Metz M; Maurer M
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):406-11. PubMed ID: 22766620
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab in chronic urticaria: a retrospective series of 15 cases.
Armengot-Carbo M; Velasco-Pastor M; Rodrigo-Nicolas B; Pont-Sanjuan V; Quecedo-Estebanez E; Gimeno-Carpio E
Dermatol Ther; 2013; 26(3):257-9. PubMed ID: 23742285
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
Song CH; Stern S; Giruparajah M; Berlin N; Sussman GL
Ann Allergy Asthma Immunol; 2013 Feb; 110(2):113-7. PubMed ID: 23352531
[TBL] [Abstract][Full Text] [Related]
11. Chronic urticaria.
Zuberbier T
Curr Allergy Asthma Rep; 2012 Aug; 12(4):267-72. PubMed ID: 22638841
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.
Saini SS; Bindslev-Jensen C; Maurer M; Grob JJ; Bülbül Baskan E; Bradley MS; Canvin J; Rahmaoui A; Georgiou P; Alpan O; Spector S; Rosén K
J Invest Dermatol; 2015 Jan; 135(1):67-75. PubMed ID: 25046337
[TBL] [Abstract][Full Text] [Related]
13. Childhood urticaria.
Marrouche N; Grattan C
Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):485-90. PubMed ID: 22825024
[TBL] [Abstract][Full Text] [Related]
14. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema.
Pressler A; Grosber M; Halle M; Ring J; Brockow K
Clin Exp Dermatol; 2013 Mar; 38(2):151-3. PubMed ID: 22731986
[TBL] [Abstract][Full Text] [Related]
15. Update on the treatment of chronic urticaria.
Curto-Barredo L; Silvestre JF; Giménez-Arnau AM
Actas Dermosifiliogr; 2014 Jun; 105(5):469-82. PubMed ID: 23664252
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab (Xolair) for chronic urticaria.
Med Lett Drugs Ther; 2013 May; 55(1417):43-4. PubMed ID: 23715129
[No Abstract] [Full Text] [Related]
17. [Chronic autoimmune urticaria: treatment with omalizumab].
Máspero JF; Parisi CA; De Gennaro M; Benhabib O; Lampert M
Arch Argent Pediatr; 2009 Oct; 107(5):452-6. PubMed ID: 19809768
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics, Investigations and Treatment in Children with Chronic Urticaria: An Observational Study.
Buono EV; Giannì G; Scavone S; Caffarelli C
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792886
[No Abstract] [Full Text] [Related]
19. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.
Büyüköztürk S; Gelincik A; Demirtürk M; Kocaturk E; Colakoğlu B; Dal M
J Dermatol; 2012 May; 39(5):439-42. PubMed ID: 22221177
[TBL] [Abstract][Full Text] [Related]
20. Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test.
Rodríguez-Trabado A; Fernández Pereira LM; Romero-Chala S; García-Trujillo JA; Cámara Hijón C
Allergol Immunopathol (Madr); 2012; 40(6):390-2. PubMed ID: 22178123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
